Cochlear's Oticon Medical acquisition under freeze order by UK CMA
( November 17, 2022, 07:57 GMT | Official Statement) -- MLex Summary: Cochlear's planned acquisition of hearing-implants business Oticon Medical from its owner Demant is subject to a freeze order by the UK Competition and Markets Authority, which prevents the parties from integrating. The CMA will decide by Dec. 6 whether the merger gives rise to competition concerns that warrant an in-depth review.Statement follows....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.